ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

CTKB Cytek Biosciences Inc

5,62
-0,42 (-6,95%)
15 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Cytek Biosciences Inc CTKB NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,42 -6,95% 5,62 06:00:04
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
5,94 5,57 6,01 5,62 6,04
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
11.6.202422:02EDGAR2Form 8-K - Current report
08.6.202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.6.202400:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.6.202414:00GLOBECytek Biosciences Announces $50 Million Stock Repurchase..
31.5.202422:48EDGAR2Form SD - Specialized disclosure report
30.5.202422:05GLOBECytek Biosciences to participate at the Goldman Sachs 45th..
28.5.202423:30GLOBE1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek®..
23.5.202400:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.5.202400:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.5.202400:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.5.202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.5.202400:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.5.202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.5.202423:30GLOBECytek® Biosciences Adds Ability to Detect Subcellular..
08.5.202422:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.5.202422:20EDGAR2Form 8-K - Current report
08.5.202422:05GLOBECytek Biosciences Reports First Quarter 2024 Financial..
30.4.202423:30GLOBECytek® Biosciences to Spotlight Cell Analysis Solutions at..
29.4.202415:00GLOBECytek Biosciences to Report First Quarter 2024 Financial..
19.3.202413:00GLOBECytek® Biosciences Names William McCombe Chief Financial..
09.3.202400:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.3.202400:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.3.202400:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.3.202400:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.3.202400:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202423:30GLOBECytek® Biosciences Opens New Facility to Address Increasing..
01.3.202412:06EDGAR2Form 8-K - Current report
28.2.202423:05GLOBECytek Biosciences Reports Fourth Quarter and Full Year 2023..
27.2.202412:06EDGAR2Form 8-K - Current report
22.2.202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202422:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07.2.202422:10GLOBECytek Biosciences to Participate in Upcoming Investor..
07.2.202422:05GLOBECytek Biosciences to Report Fourth Quarter and Full Year..
17.1.202423:30GLOBECytek® Biosciences Signs Agreement with CRG and UPF to..
09.1.202412:05EDGAR2Form 8-K - Current report
08.1.202415:00GLOBECytek Biosciences Announces Preliminary Full Year 2023..
28.12.202322:05GLOBECytek Biosciences to present at the 42nd Annual J.P. Morgan..
27.12.202323:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202323:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202315:00GLOBECytek® Biosciences Introduces the Cytek Orion™ Reagent..
19.12.202322:28EDGAR2Form 144 - Report of proposed sale of securities
28.11.202313:00EDGAR2Form 8-K - Current report
28.11.202302:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202302:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.11.202323:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock